Enfuvirtide and T-1249 are two potent HIV-1 fusion inhibitor peptides. Recent studies indicate that lipids play an important role in the mode of action of those bioactive molecules. Using a combined tandem atomic force microscopy (AFM)-epifluorescence microscopy approach, we studied the interaction of both enfuvirtide and T-1249 with supported lipid bilayers. Fluid (l d )-gel (s o ) and l d -liquid ordered (l o ) phase-separated membrane systems were tested. Results, especially for T-1249, show significant lipid membrane activity at a 15 μM peptide concentration. T-1249, in opposition to enfuvirtide, induces an increase in membrane surface roughness, decrease in membrane fluidity, bilayer thinning at l d domains and disruption of the s o domain borders. In terms of structural properties, both enfuvirtide and T-1249 possess distinct functional hydrophobic and amphipathic domains of HIV gp41. While enfuvirtide only yields the tryptophan-rich domain (TRD), T-1249 possesses both TRD and pocket-binding domain (PBD). TRD increases the hydrophobicity of the peptide while PBD enhances the amphipathic characteristics. As such, the enhanced membrane activity of T-1249 may be explained by a synergism between its amphipathic N-terminal segment and its hydrophophic C-terminal. Our findings provide valuable insights on the molecular-level mode of action of HIV-1 fusion inhibitors, unraveling the correlation between their structural properties and membrane interactions as a factor influencing their antiviral activity. Ultimately, this work validates the applicability of a combined AFM and fluorescence approach to evaluate the mechanic and structural properties of supported lipid bilayers upon interaction with membrane-active peptides.
Introduction
Fusion inhibitor (FI) peptides are a recent and promising class of human immunodeficiency virus type 1 (HIV-1) antiretrovirals [1] [2] [3] . These molecules have demonstrated superior activity, which ultimately led to the FDA-approval of enfuvirtide (T-20, Fuzeon) in 2003 [4] . FIs present advantages in comparison to conventional anti-HIV drugs, such as lower toxicity, increased biodistribution and reduced resistance levels. FIs interfere with processes on the surface of cells and viruses before target cell infection. They inhibit highly conserved regions on the HIV-1 envelope glycoprotein 41 (gp41), the protein responsible for the viral pore formation and membrane fusion [1, 2] . More specifically, FIs interfere with the formation of the 6-helix bundle (6HB) originated by the interaction of the C-terminal heptad repeats (CHR or HR2) with the N-terminal heptad repeats (NHR or HR1) of gp41 [5] . Enfuvirtide and other similar peptide inhibitors are derived from CHR regions and, therefore, are able to competitively bind to the HIV-1 gp41 NHR. Although FIs typically act via binding to gp41, some specificities related to their mode of action should be pointed out [6] [7] [8] [9] . On the native HIV-1 envelope structure the conserved gp41 HR domains are most of the time shielded within the gp120-gp41 envelope protein complex tridimensional structure and, thus, hardly accessible in aqueous solution. The exception is during the fusion process, when the HR domains are exposed in order to form the 6HB. Therefore, the inhibition by FIs must occur in a limited time window under extreme confinement between the viral envelope and cell plasma membrane. One way to overcome these limitations is to improve the interaction of FIs with lipid membranes. The viral and plasma cell membranes can serve as platforms to concentrate the inhibitor molecules that become this way directly accessible near the fusion site. A correlation between membrane binding and antiviral efficacy has been established: for instance, FIs in which lipophilic moieties were added to enhance the interaction with membranes have proven to possess improved antiviral activity [10, 11] .
Enfuvirtide [12] has 36 amino acid residues, roughly including 26 residues of gp41 CHR and 10 residues from the gp41 membrane proximal external region (MPER). Part of the MPER is enriched in tryptophan residues, forming a hydrophobic tryptophan-rich domain (TRD) (Fig. 1 ).
This specific domain is the one responsible for the activity of enfuvirtide and is involved in the binding of the molecule to lipids [13] . Thus, this region is additionally known as lipid binding domain (LBD) .
In comparison with other FIs, such as T-1249, which is a 39 amino acid residue peptide derived from HIV-1, HIV-2 and simian immunodeficiency virus (SIV) [14] , enfuvirtide possesses the TRD but lacks another gp41 functional domain known as pocket binding domain (PBD) (Fig. 1 ). This domain is responsible for the efficient binding of FIs to the deep pockets formed by gp41 NHR trimers [15] . Inhibitors that possess such domains have demonstrated to inhibit the 6HB formation more efficiently [16] . While the TRD seems to be the region responsible for the interaction of FI peptides with lipid membranes, one cannot discard the importance of the PBD in the interactions with lipids. For instance, we previously showed that sifuvirtide, a recently developed peptide inhibitor that lacks the TRD, is able to interact selectively with rigid phosphatidylcholine (PC) membranes [17, 18] , despite showing no significant affinity for zwitterionic fluid membranes. The involvement of the PBD and TRD in membrane interactions may be expected from the theoretical α-helical representation of the peptides. As seen in Fig. S1 (Appendix A), if we depict enfuvirtide and T-1249 as α-helices, both peptides display a highly hydrophobic C-terminal helix (due to the presence of the TRD), and T-1249 displays an N-terminal amphipathic helix (due the presence of the PBD).
As such, the aim of this work was to unravel the molecular foundation of FI peptides-lipid interactions using a combination of microscopy techniques. Microscopy allows obtaining high-resolution information related to the interaction of enfuvirtide and T-1249 with lipid bilayers. It would enable, for instance, the imaging of the effects that those drugs have on the lipid bilayer architecture.
Atomic force microscopy (AFM), a scanning-probe technique able to provide topography and force measurements [19] , was coupled with epifluorescence microscopy [20] in order to obtain simultaneous topographic and bidimensional organization information on the lipid bilayer properties. Supported lipid bilayers (SLB) deposited on freshly-cleaved mica were used as our major lipid membrane model. Despite the variety of phospholipids that compose the HIV viral and cell plasma membranes, including phosphatidylcholines (PC), sphingomyelins (SM), phosphatidylethanolamines (PE) or phosphatidylserines (PS), in order to control the fluidity and phase properties of the bilayers and avoid biases arising from the repulsion between anionic lipids and the negatively-charged mica surface, mixtures containing solely uncharged PC and also cholesterol were used throughout this work. Here we wanted to evaluate if the presence of both PBD and TRD on a FI is in fact able to promote enhanced membrane interaction profiles that can be correlated with an enhanced antiviral activity. In the end, our results provide novel information on the structural properties adopted by FIs while interacting with membranes displaying specific phase separations.
Material and methods

Reagents and instruments
Enfuvirtide and T-1249 were kind gifts from Roche (Palo Alto, CA). Combined (and/or separated) AFM-epifluorescence measurements were performed on a JPK Instruments Nanowizard II (Berlin, Germany) mounted on a Carl Zeiss Axiovert 200 inverted microscope (Jena, Germany).
Solutions were prepared in 10 mM HEPES buffer pH 7.4, 150 mM NaCl. This buffer was used throughout the studies, unless otherwise stated. All the experiments were performed at 23°C.
Planar supported lipid bilayer preparation
Supported lipid bilayers (SLB) were prepared by deposition of small unilamellar vesicles (SUV), as described elsewhere [21, 22] . Briefly, 50 μL of 1 mM SUV suspension, obtained by sonication, was deposited in the presence of 2 μL CaCl 2 0.1 M on a freshly cleaved mica substrate previously glued to a glass coverslip. The sample was then incubated for a maximum time of 20 min at a temperature above the lipid mixture phase transition temperature (T m ). After incubation, the sample was rinsed at least 4 times with EDTA 1 mM and afterwards at least 10 times with buffer, in order to remove unfused vesicles. The planar bilayers were then allowed to cool down and equilibrate for at least 1 h. On the lipid membranes labeled with di-8-ANEPPS, its molar percentage was kept below 0.33%.
Atomic force microscopy measurements
Imaging was performed using uncoated silicon nitride cantilevers OMCL-TR800PSA-2 (Olympus, Tokyo, Japan), with a typical stiffness of 0.57 N/m for intermittent contact and a typical stiffness of 0.15 N/m for contact mode. All images, for the different peptides, concentrations and lipid compositions evaluated, were obtained with the same or close AFM parameter (setpoint, scan rate, gain) values. The scan rate was set to less than 1 Hz for intermittent contact mode and between 1.5 and 4 Hz for contact mode. The force applied on the sample was maintained at the lowest possible value by continuously adjusting the setpoint and gain during the imaging. Typically, setpoints close to 0.7 V for intermittent contact and 0.3 V for contact modes were used. For intermittent contact mode the cantilever oscillation was tuned to a frequency of 15-20 kHz. Height, error, deflection and phase-shift signals were collected and images were line-fitted as required. Tip artifacts were ruled out by image analysis [23] . Images were obtained at least for 3-5 regions of the lipid bilayers. Control experiments with buffer instead of enfuvirtide or T-1249 were also performed.
Roughness analysis for some of the AFM height images (but also for AFM error images and epifluorescence images) was performed using the approach described by Alves et al. [24] . The roughness was calculated from the root mean square value (RMS; i.e. standard deviation, of the distribution of heights, or other parameter). RMS values were measured over the entire images and RMS maps were obtained. RMS values on l d , l o and s o domains were compared within each map.
Force measurements were performed on POPC bilayers using uncoated silicon cantilevers CSC38 from MikroMasch (Tallinn, Estonia), with a spring constant of 0.12 N/m, as previously described [21] . Briefly, the calibration of the sensitivity, resonance frequency and effective spring constant (via thermal noise method) of the cantilever was performed before and after each experiment. The total z-piezo displacement was always 200 nm; the indenting approach speed was set at 800 nm/s, while the retraction speed was 200 nm/s. Force measurements were carried out at different points of the lipid bilayers. After identification of the membrane breakthrough events on an average of 225 approach force curves, the retrieved yield forces, for each experiment, were plotted in histograms [25] .
Statistical analysis of the AFM data was performed using one-way analysis of variance (ANOVA) followed by Bonferroni multiple comparison test (interval of confidence 95%).
Epifluorescence imaging
Epifluorescence imaging was conducted on the Zeiss microscope where the AFM instrument is mounted. Fluorescence illumination was achieved using an EXFO X-Cite 120 light unit (Mississauga, Canada) with a high pressure 120 W metal halide short arc lamp, utilizing a Zeiss filter set 09 (excitation BP 450-490; beamsplitter FT 510; emission LP 515) and using a Zeiss 100× NA 1.3 UV-VIS-IR EC Plan-Neofluar oil-immersion objective. For detection, a Hamamatsu Photonics C9100-13 Electron Multiplier CCD camera (Hamamatsu City, Japan) was further used. Fluorescence images were acquired with a 512 × 512 pixel resolution, under normal CCD mode, using exposure times below 1 s. Images were obtained at least for 3-5 regions of the lipid bilayers. Control experiments with buffer instead of enfuvirtide or T-1249 were also performed. [26] lipid bilayers. These mixtures were used since they form stable and defined l d -s o and l d -l o phase separated domains [27, 28] . No major architectural modifications occurred on POPC:DPPC and DOPC: DSPC:Chol bilayers when enfuvirtide was added at a 1.5 μM concentration. On the other hand, at 15 μM enfuvirtide, small membrane disruptions (≈1 nm) on the l d matrix present at approximately 20% of the scanned areas were detected at the borders of the POPC:DPPC l d -s o phase separations ( Fig. 2A ). On DOPC:DSPC:Chol bilayers, larger aggregates appeared on the surface of the membranes (Fig. S2A ). These can be assigned to peptide-lipid complexes adsorbed on the surface of the rigid cholesterol-enriched l o domains. The complexes may be formed due to membrane solubilization or due to the disruption by the peptide of unbound vesicles [26] .
T-1249 at a 1.5 μM concentration did not promote significant perturbations on the membrane, except for small aggregates that appeared on the surface of the cholesterol-enriched l o domains on DOPC:DSPC:Chol bilayers (Fig. S2B, Appendix A) . However, at the higher concentration, a major interaction was detected. On POPC: DPPC bilayers, an increase of the roughness of the l d POPC matrix and a slight perturbation of the s o phase borders were detected (Fig. 2B) . These results show a preferential interaction and insertion of the peptide on those membrane regions. On the other hand, large aggregates were present on the surface of DOPC:DSPC:Chol bilayers but no perturbation of the l o borders was observed. The large aggregates, mainly on the DOPC fluid matrix, may correspond to lipid and peptide aggregates/vesicles that are being removed from the lipid bilayer, similar to the effect of detergent-like molecules [29] .
Due to the presence of peptide aggregates on DOPC:DSPC:Chol bilayers (Fig. S2 , Appendix A), it was not possible to perform an accurate roughness analysis on these systems. Roughness mapping, using the root-mean square (RMS) calculation [24] , was only performed for the acquired POPC:DPPC AFM images. At 1.5 μM peptide concentration no significant differences in the RMS values between l d and s o domains were detected for enfuvirtide and T-1249. In contrast, at a 15 μM peptide concentration, an increase of the RMS of the fluid l d matrix was clearly shown (Fig. 2) . To analyze the RMS images in more detail, we calculated the ratio of the RMS values between l d and s o domains. For enfuvirtide, there is a slight increase in the RMS ratios from 1.00 ± 0.07 (without peptide) to 1.17 ± 0.11 (at 1.5 μM peptide) and 1.23 ± 0.08 (at 15 μM peptide). For 1.5 μM T-1249 a slight increase, from 1.00 ± 0.09 to 1.19 ± 0.09, is also detected. However, at 15 μM T-1249 the RMS ratio is 2.76 ± 0.21, showing that the presence of this peptide in the POPC: DPPC bilayer caused approximately a 3-fold increase in the roughness of the l d membrane relative to s o . An increase in membrane roughness (and membrane morphological changes) has been already reported for other HIV-related molecules such as HIV gp41 protein in the post-fusion state [30] and NHR-derived peptides [31] .
Effect of the fusion inhibitors' incubation time on the lipid bilayer structure
A kinetic AFM study, under intermittent contact mode, was also performed with POPC:DPPC bilayers. Fig. 3 shows the effects of the incubation with 15 μM T-1249 at distinct time points (2 and 12 h ). An increase in the roughness on the fluid POPC region was clearly observed both in height and error images. Furthermore, the borders of the s o domains are slightly perturbed and a thinning of the membrane after the addition of peptide is also detected. As the cross-sections depicted in Fig. 3B show, after the addition of T-1249, the s o -l d height difference is more pronounced, increasing from 1.0-1.2 nm prior the addition to 1.5-1.8 nm after the addition of 15 μM peptide. The extent of the thinning is in agreement with the in-depth location of T-1249 in POPC membranes, determined using fluorescence spectroscopy (Trp residues of the peptide at a 16-17 Å distance from the bilayer center) [32] , and may be related to the interfacial insertion of the peptide between the lipid headgroups. A similar membrane effect, already visualized by AFM, has been described for an amphipathic α-helical peptide derived from a hepatitis C viral protein [33] . Overall, the effects here described for T-1249 at 15 μM on POPC:DPPC membranes (Fig. 3 ) are stable at least for 12 h, the last time-point evaluated. 
Evaluation of the interaction of fusion inhibitors using combined contact mode AFM and epifluorescence
We further performed a combined AFM contact mode and epifluorescence acquisitions. Membranes were labeled with di-8-ANEPPS, a probe only significantly fluorescent in lipidic environments [35, 36] . Our observations showed a preferential partition of this probe into the fluid l d domains. First, epifluorescence images of the lipid bilayers (size 83 × 83 μm 2 ) were acquired. Then a second image was acquired after 45 min incubation of the peptides (at 15 μM) with the lipid bilayers. After 60 min incubation, AFM images were taken on specific regions previously detected on the epifluorescence image. The membrane domains observed on the epifluorescence images (Fig. S4A , Appendix A) of DOPC:DSPC:Chol membranes were very small in size, with an approximate diameter of 0.5-3 μm. On the other hand, the domains observed on POPC:DPPC lipid bilayers were much larger (Fig. 4A) , allowing for a more accurate evaluation of RMS images (Fig. 4B) . The RMS calculation of epifluorescence images enabled us to evaluate heterogeneities in the probe's lateral distribution that might have occurred at the lipid bilayer level upon the addition of peptide. For instance, the fluorescence on the POPC matrix became less homogenous with the addition of 15 μM T-1249. By performing the RMS analysis of those fluorescence images (Fig. 4B ) an approximate 3-fold increase in the RMS of the POPC l d matrix is detected for T-1249, but not for enfuvirtide.
Images obtained by contact mode AFM (Fig. 4C ) also demonstrated the same pattern, as previously described for intermittent-contact mode and epifluorescence images. While the RMS upon addition of buffer or enfuvirtide is similar all over the lipid domains, the addition of T-1249 promotes an approximate 3-fold increase in the RMS of the POPC matrix. More detailed AFM images revealed that the increase in roughness is due to the insertion of peptide and fragmentation of the s o phase borders; thus, smaller islets of s o phase DPPC domains are present in the l d POPC matrix.
In the case of DOPC:DSPC:Chol bilayers, upon the addition of buffer or enfuvirtide, AFM images (Fig. S4B , Appendix A) demonstrated no significant perturbations of the lipid bilayer, except some sparse holes with a typical depth of ≈3.5 nm. However, when T-1249 was added, more holes become present all over the lipid bilayer. This effect, detected on DOPC fluid regions but non-significant for membranes containing POPC or more rigid lipids, can be explained by a detergent-like behavior of the peptide, removing lipid primarily from the more fluid DOPC regions. Furthermore, these holes have a typical depth of ≈2 nm, which can be explained by the thinning of the bilayer or by the removal of the upper monolayer by the peptide. The formation of such holes in planar bilayers has been already detected by AFM for several peptides, such as antimicrobial peptides [37] , amyloidogenic peptides [38] and, most significantly, the HIV-1 fusion peptide [31] . For the RMS analysis of the DOPC:DSPC: Chol AFM images (Fig. S4C) , only with T-1249 an increase is detected. The regions with higher roughness correspond to those previously described as having holes. Unlike intermittent contact mode AFM (Fig.  S2) , no major aggregates are seen in contact mode, which may be due to the facilitated dragging of adsorbed material caused by the continuous contact between the AFM tip and the sample.
Assessment of the interaction of fusion inhibitors using force measurements
While all the imaging experiments showed an enhanced effect of T-1249 on lipid bilayers, especially for POPC fluid membranes, we decided to evaluate if the peptide would also promote changes on the mechanical properties of the membrane. Besides imaging, AFM can be used to measure forces. In this mode, the cantilever deflection is recorded as a function of the z-piezo displacement, which relates to the force applied by the AFM tip on the sample versus the tip-sample distance [25] . While measuring force curves on supported membranes, typically a discontinuity or jump is observed when the tip compresses the sample [25] , as shown in Fig. 5A . This event corresponds to a certain yield force, which is interpreted as the penetration of the AFM tip through the bilayer. In other words, this event corresponds to the force needed for the tip to break through the supported lipid bilayer (or simply the breakthrough force in short), which is directly linked to the mechanical properties of the bilayer.
In this section, instead of using phase-separated bilayers, we used pure POPC homogeneous membranes in order to reduce the complexity of the system for a quantitative force analysis [21] . Here, we recorded an average of 225 force curves on POPC bilayers prior and after the 1 h incubation with 15 μM enfuvirtide or T-1249. We evaluated the breakthrough events and recorded the forces needed for the tip to perforate the lipid bilayer. The values were then compiled on the histograms shown in Fig. 5B . POPC membranes displayed an average breakthrough force of 2.4 nN. The addition of enfuvirtide caused no significant changes on this value. However, when 15 μM T-1249 was added, an approximate 3-fold reduction in the force needed for the tip to break the lipid bilayer was detected. This indicates that the peptide is fluidifying the membranes, in accordance with the previously described insertion of the peptide, increase in membrane roughness and membrane thinning. A similar behavior was reported by Garcia-Saez et al. for a Bax-derived peptide [21] .
Intrinsic membranotropic effects of the hydrophobic functional domains
The previously presented results show an enhancement of the membranotropism of T-1249 in comparison to enfuvirtide at a global concentration of 15 μM. This is in agreement with previous results [32, 39] , in which we demonstrated, using fluorescence spectroscopy, that T-1249 presents a 3-fold higher partition coefficient (K p ) for POPC membranes, when compared to enfuvirtide (5.1 × 10 3 vs. 1.6 × 10 3 , respectively). Despite some minor differences in net charge and hydrophobicity on the residues that enfuvirtide and T-1249 share, the major differences in membrane affinity between the two peptides can be pinpointed to the presence or absence of the PBD. In order to ascertain the intrinsic effect of the synergism between PBD and TRD, we evaluated the effect of enfuvirtide and T-1249 at comparable membrane-bound concentrations.
From the previously indicated K p values, one can calculate the fraction of membrane-bound (x L ) enfuvirtide and T-1249, as described in [40] . Considering the diameter of the mica substrate used to deposit the supported bilayer, the experimental volume and the surface area of the phospholipids used, one can estimate the amount of lipid involved in the formation of supported membranes and subsequently determine the fraction of membrane-bound enfuvirtide and T-1249: for enfuvirtide, 4.1%; for T-1249, 13%. Thus, in order to have comparable amounts of membrane-bound enfuvirtide and T-1249, a global experimental concentration of 15 μM T-1249 (~200 nM within the membrane volume) and a global concentration of 47.5 μM enfuvirtide can be tested by AFM. As seen in Fig. S5 (Appendix A), even at a comparable membrane-bound concentrations, enfuvirtide and T-1249 display distinct membrane-interaction patterns on POPC:DPPC (1:1) membranes. In the presence of 47.5 μM enfuvirtide, aggregation was observed on top of POPC:DPPC bilayers. In opposition, for 15 μM T-1249, insertion of the peptide on l d domains and an increase in membrane roughness are detected. This distinct behavior demonstrates a cooperative role of the PBD and TRD for the enhancement of the membrane activity of FIs.
In addition, peptides presenting only the PBD region have been reported to have low to non-significant affinity towards lipids. Liu et al. [13] demonstrated, for instance, that the FI peptide C36 does not interact significantly with POPC vesicles. Sifuvirtide, a recent FI derived from the CHR region of gp41, presents a selective, albeit rather weak adsorption to DPPC gel phase vesicles [17, 18] . Fig. S6 (Appendix A) shows that, for a global concentration of 15 μM sifuvirtide, no significant effects on the POPC:DPPC (1:1) supported lipid bilayer architecture are revealed using AFM imaging. These results are in agreement with a major role displayed by the TRD on the interactions of enfuvirtide or T-1249 with membranes, reinforcing the conclusion of a mechanism of functional cooperation between the PBD and TRD for the interaction of T-1249 with lipid membranes.
Conclusions
HIV gp41 CHR-derived FI peptides are molecules that contain multifunctional domains [41] . Distinct mechanisms of action may provide more alternatives to tackle HIV-1 inhibition. The modulation of the structure of CHR-derived FIs and the inclusion of the PBD and TRD, individually or simultaneously, give rise to FIs with distinct capabilities. Considering the emergence of drug-resistant HIV-1 variants, having in the near future efficient alternatives to the FDA-approved drug enfuvirtide is one of the primary goals in the field of HIV treatment. For that reason, understanding the details underlying the mechanisms of action of FIs, including interactions with lipid membranes, is fundamental.
In this work, we studied the mode of action at the lipid membrane level of two FIs: enfuvirtide and T-1249. As seen in Fig. 1 , both peptides possess the gp41 TRD at the C-terminal, but only T-1249 has the N-terminal PBD [41] . While the TRD may enhance the hydrophobicity of the peptide, the PBD on the other hand enhances the peptide's amphipathic characteristics (Fig. S1, Appendix A) . We followed the interaction of both peptides with lipid membranes by AFM and epifluorescence microscopy. The results demonstrated that T-1249 has an increased affinity for lipid membranes, mainly for fluid l d POPC membranes, with an increase in membrane roughness due to peptide insertion, membrane thinning and fluidification. While it was also proven that enfuvirtide has affinity for lipids, the extent and complexity of this interaction are lower when compared to T-1249. Moreover the differences between enfuvirtide and T-1249 in terms of membrane interaction cannot solely be attributed to the fraction of membrane-bound peptide, neither to the action of the PBD region by itself (as seen from the interaction of sifuvirtide with supported lipid bilayers [18] ). Hence, the major differences observed here can be correlated to the presence of tandem PBD-TRD functionality in T-1249, enhancing its lipid interaction profile.
Distinct roles for the TRD and PBD regions of FI peptides have been proposed by several groups (see references [1, 2] for more details). Liu et al. [13] proposed that peptides presenting the PBD inhibit HIV-1 fusion by interacting with gp41 NHR, forming stable 6HB and blocking gp41 core formation; while peptides lacking the PBD and possessing the C-terminal TRD (such as enfuvirtide) would block viral fusion by binding to gp41 NHR and by binding its C-terminal sequence to cell membranes. While the role of the TRD as promoter of the interaction of FIs with membranes has become widely accepted, seminal results in the literature may have already pointed out this putative role of the PBD in the modulation of interaction of FIs with lipids. Yet the topic was still poorly addressed until now. For instance, Wexler-Cohen et al. already demonstrated that peptides similar to enfuvirtide, but truncated at the C-terminal in order to lack the TRD, partially or fully regain antiviral activity upon the addition of a lipophilic moiety at the C-terminal (native position of the TRD region), N-terminal (native position of the PBD region) or both [42] . Qi et al. also demonstrated that peptides possessing artificial HR and containing both TRD and PBD presented higher antiviral potency and increased lipid membrane affinity, when compared to peptides formed by artificial HR containing only either the C-terminal TRD or the N-terminal PBD [43] . Recently, small molecules that bind the hydrophobic deep pocket on the gp41 NHR core (the region to which the PBD region binds) have been reported to present affinity for fatty acid salts [44] and lipid membranes [45, 46] . Finally, our previous results with enfuvirtide [39, 47] , T-1249 [32, 47] and sifuvirtide [17, 18, 48] using lipid membrane models, erythrocytes and PBMC enabled us to hint that cooperation between the hydrophobic domains at both ends of CHR-derived fusion inhibitors could dictate efficacy based on the membrane interaction of those antiviral molecules.
In summary, the results in this work provide insights concerning the mode of action and the role of both PBD and TRD regions in the modulation of the lipid membrane interaction profiles of FI peptides. T-1249, which contains both functional domains, has an enhanced affinity for lipid membranes. This enhanced tropism can be explained by the cooperation and synergism of both hydrophobic C-terminal end and amphipathic N-terminal end of the peptide, which ultimately improves several folds the interaction with lipid membranes. Potentiating membrane interactions, aside from the direct binding to gp41, is a crucial factor to be taken into consideration during the design and development of more efficient antiretrovirals against HIV. This work also demonstrates that biophysical techniques such as tandem AFM and fluorescence methodologies, with tailored data analyses, are capable of providing clear and detailed information concerning the mode of action of membrane-active molecules.
